drugs for rare cancers approved after subpar tests
drugs for rare cancers are allowed to hit the u.s. market based on low-quality clinical tests that raise concerns about both safety and efficacy, researchers said monday.
http://feeds.reuters.com/~r/reuters/healthnews/~3/atxbyukmzic/us-drugs-cancers-idustre7556hp20110606
23470
06 Jun 2011 23:39:05
reuters
health